Twist Bioscience
TWST· Manufacturing· Fiscal year ends in September
Emily Leproust is the CEO of Twist Bioscience and was paid $13.8M in FY2025 (Sep), up 81%.
Executives5
See all- 1Emily LeproustPh.D. Chief Executive Officer and Chair of the BoardFY2025
- 2Patrick Finn, Ph.D.President and Chief Operating OfficerFY2025
- 3Adam LaponisChief Financial OfficerFY2025
- 4Dennis ChoChief Legal Officer and Corporate SecretaryFY2025
- 5Paula GreenSenior Vice President of Human ResourcesFY2025
Named executives and their total pay, from the Summary Compensation Table of the latest proxy.
Pay
See allTwist Bioscience paid its 5 named executives $33.0M in total in FY2025 (Sep). CEO Emily Leproust was paid $13.8M of that.
| Name | |||
|---|---|---|---|
| Emily LeproustPh.D. Chief Executive Officer and Chair of the Board | |||
| Patrick Finn, Ph.D.President and Chief Operating Officer | |||
| Adam LaponisChief Financial Officer | Not disclosed | ||
| Dennis ChoChief Legal Officer and Corporate Secretary | |||
| Paula GreenSenior Vice President of Human Resources |
of each named executive, from the Summary Compensation Table of each proxy.
Peers17
See allThe FY2025 (Sep) proxy of Twist Bioscience names 17 peer companies for pay. Among Twist Bioscience and these peers, CEO pay was 3rd highest of 7 and total shareholder return was 4th highest of 7.
3rd highest of 7in Twist Bioscience and its pay peers, FY2025 (Sep) by CEO pay:
4th highest of 7in Twist Bioscience and its pay peers, FY2025 (Sep) by total shareholder return:
The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year.
Board3
See all- Keith L. CrandellDirector · 11 yr on the boardIndependentCompensation, Nominating and Corporate Governance—Paid as an executive
- Robert RagusaDirector · 8 yr on the boardIndependentAudit and Risk, Compensation—Paid as an executive
- Melissa A. Starovasnik, Ph.D.Director · 3 yr on the boardIndependentCompensation (Chair)—Paid as an executive
The board of the latest proxy (FY2024).
Activity
Filings6
See all| Proxy statement | DEF 14A | Jan 6, 2026 | FY2025 |
| Annual report | 10-K | Nov 17, 2025 | FY2025 |
| Proxy statement | DEF 14A | Jan 6, 2025 | FY2024 |
| Annual report | 10-K | Nov 18, 2024 | FY2024 |
| Proxy statement | DEF 14A | Jan 5, 2024 | FY2023 |
| Annual report | 10-K | Nov 21, 2023 | FY2023 |
